Nf-kappa B, chemokine gene transcription and tumour growth
about
Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathwayRecent advances on tea polyphenolsGB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVSInhibitors of apoptosis proteins in human cervical cancer.Regulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewMolecular therapy of colorectal cancer: progress and future directionsRadiation-induced immune responses: mechanisms and therapeutic perspectivesRas promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cellsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesXenograft tumors vascularized with murine blood vessels may overestimate the effect of anti-tumor drugs: a pilot studyControl of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.Visualization of AP-1 NF-kappaB ternary complexes in living cells by using a BiFC-based FRET.Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment.Interleukin-1beta induces macrophage inflammatory protein-1beta expression in human hepatocytes.Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-кB pathway.Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approach.RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.Activation of lipid metabolism contributes to interleukin-8 production during Chlamydia trachomatis infection of cervical epithelial cellsNEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population.Conditional ablation of Ikkb inhibits melanoma tumor development in mice.Nardostachys jatamansi extract protects against cytokine-induced beta-cell damage and streptozotocin-induced diabetes.Krüppel-like factor 5 mediates proinflammatory cytokine expression in lipopolysaccharide-induced acute lung injury through upregulation of nuclear factor-κB phosphorylation in vitro and in vivoInhibiting NF-κB activation by small molecules as a therapeutic strategy.Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology GroupTransient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature.Targeting IL-8 in colorectal cancer.Cancer-promoting effects of microbial dysbiosis.Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways.Multitargeted therapy of cancer by green tea polyphenols.Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.BLT2 up-regulates interleukin-8 production and promotes the invasiveness of breast cancer cells
P2860
Q24306909-F5312F2E-E96D-4762-8691-A2C0C6A47362Q24616890-9211F4BD-2AB3-4C2F-B336-BE845EE9DFD2Q24675888-EF547FB4-8D7A-4C6C-BCC3-C84B0D2E9978Q25255294-2FF21CDE-ADEE-4A77-A735-AFA0782B16EBQ26749588-1A9EEB0F-1BCE-48C7-9C14-1C6E2169AF3EQ26866236-EA4F0F57-70B7-4631-B366-A7A116C3D5E4Q26995835-333DEEE0-C6D5-4AD0-9099-B1B81F6B665AQ27005764-9F3BA3E8-6494-4465-AA2C-77FD0E44BB44Q28080006-D460D1E2-B582-4638-AF7F-418D6EC32734Q28243232-6BC271E5-99F2-4DAA-8F79-A56B485D1C08Q28388335-E055E3A4-4E7F-4802-9EF7-998199EB3E24Q28538185-6AB15A03-E1E9-4B8E-93C7-0AEB233898C2Q29614206-32C2ACB4-4D13-4B69-898A-0938439F675EQ30414471-7B4C9EC6-1594-4FE2-A0AA-93152BC16993Q31071791-2F2356F3-DC80-4E61-87B7-ACADA75CB35BQ33313079-83862068-FD49-436F-AC27-30C0E0F67336Q33530911-2370B802-1A3F-481A-B9F0-AEB435D5945CQ33593863-D536AB7C-510D-44CA-ADB4-1EDCC6DA7F0BQ33688881-157DDE42-4C3F-49C0-B5C0-F221317B4224Q33694518-D7A575B4-549A-49BE-870F-E84A5AC85724Q33700555-40BAF0DA-C30F-443B-9C1E-7B1C158C4116Q33848457-25ACD877-3701-476C-A95C-736154AF5D04Q33850829-259B293A-58DC-42F6-97F2-BF21AECEB415Q33883405-CB30D8AC-01B1-4787-A7E4-C27F8A553CEEQ33887749-070BC90C-5C44-443B-96AC-4D1C6B83F700Q33955330-C9CDD265-145D-4078-83FF-2B9C03CA810BQ33968131-F9934644-6672-4344-8632-74C6851BAA3DQ33978124-D30C0112-DD16-43B9-9AF7-F56C32ACCF9CQ34096535-A0FA7263-1F89-4961-B3C4-81A834A3C671Q34205025-128240A0-A068-4632-8FC1-28D3C9CCDB27Q34225158-C02525A7-7FE8-4F1D-BAC3-DA60C043AA43Q34233871-A84E98D5-2A45-4E11-BFF6-099A860FA0D3Q34241444-A138A31A-1BDF-4DD4-B337-0E2E7B567AE2Q34267408-A7F31CD4-6ADA-4F74-8AE7-56F428EEC327Q34267734-F30B70E2-9066-4791-B119-B0F931FF86C1Q34270866-E6678FB1-D306-4F9E-A8BC-1827576667F2Q34344752-65DF778C-6BB2-47AC-8CC4-8E4E87947882Q34374910-84D1137F-318C-4ADA-B7C1-C5D160C8592CQ34467504-9A665AC0-517C-47A6-BB90-34FC2E8E8F9CQ34474210-27E27713-E408-442E-B484-39430B0A0EFE
P2860
Nf-kappa B, chemokine gene transcription and tumour growth
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nf-kappa B, chemokine gene transcription and tumour growth
@ast
Nf-kappa B, chemokine gene transcription and tumour growth
@en
Nf-kappa B, chemokine gene transcription and tumour growth
@nl
type
label
Nf-kappa B, chemokine gene transcription and tumour growth
@ast
Nf-kappa B, chemokine gene transcription and tumour growth
@en
Nf-kappa B, chemokine gene transcription and tumour growth
@nl
prefLabel
Nf-kappa B, chemokine gene transcription and tumour growth
@ast
Nf-kappa B, chemokine gene transcription and tumour growth
@en
Nf-kappa B, chemokine gene transcription and tumour growth
@nl
P2860
P356
P1476
Nf-kappa B, chemokine gene transcription and tumour growth
@en
P2093
Ann Richmond
P2860
P304
P356
10.1038/NRI887
P577
2002-09-01T00:00:00Z